Manu Moudgil, Indiaspend.com/FactChecker.in India has had guidelines for rolling out pre-exposure prophylaxis (PrEP)—a medicine that reduces the risk of HIV infection—since 2022. Four years later, government centres do not distribute it. PrEP remains available only in the private market at Rs 2,200 to Rs 3,000 a month, or through a handful of non-profits in select … Continue reading 4 years after guidelines, India’s HIV prevention tool remains a privilege